These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24834878)

  • 1. Development of a dosage form for accelerated release.
    Waldner C; Friedl HE; Dünnhaupt S; Köllner S; Leonaviciute G; Bernkop-Schnürch A
    Int J Pharm; 2014 Aug; 471(1-2):189-96. PubMed ID: 24834878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability.
    Alam N; Beg S; Rizwan M; Ahmad A; Ahmad FJ; Ali A; Aqil M
    Drug Dev Ind Pharm; 2015 Apr; 41(4):692-702. PubMed ID: 24669975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regenerated cellulose capsules for controlled drug delivery: Part III. Developing a fabrication method and evaluating extemporaneous utility for controlled-release.
    Bhatt B; Kumar V
    Eur J Pharm Sci; 2016 Aug; 91():40-9. PubMed ID: 27262541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regenerated cellulose capsules for controlled drug delivery: Part IV. In-vitro evaluation of novel self-pore forming regenerated cellulose capsules.
    Bhatt B; Kumar V
    Eur J Pharm Sci; 2017 Jan; 97():227-236. PubMed ID: 27916694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-independent pulsatile drug delivery system based on hard gelatin capsules and coated with aqueous dispersion Aquacoat ECD.
    Mohamad A; Dashevsky A
    Eur J Pharm Biopharm; 2006 Oct; 64(2):173-9. PubMed ID: 16814532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of osmotic pump capsules containing polyoxyethylene and pH modifier to control the release of nifedipine.
    Yu J; Meng X; Dong X; Han M; Li G; Chen Y; Liu Y; Hu L
    Eur J Pharm Biopharm; 2021 Jun; 163():102-108. PubMed ID: 33819628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of sustained release capsules by electrostatic dry powder coating, using traditional dip coating as reference.
    Yang Y; Shen L; Yuan F; Fu H; Shan W
    Int J Pharm; 2018 May; 543(1-2):345-351. PubMed ID: 29601974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an intestinal pressure-controlled colon delivery capsules prepared by a dipping method.
    Jeong YI; Ohno T; Hu Z; Yoshikawa Y; Shibata N; Nagata S; Takada K
    J Control Release; 2001 Apr; 71(2):175-82. PubMed ID: 11274749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmotic capsules: A universal oral, controlled-release drug delivery dosage form.
    Waterman KC; Goeken GS; Konagurthu S; Likar MD; MacDonald BC; Mahajan N; Swaminathan V
    J Control Release; 2011 Jun; 152(2):264-9. PubMed ID: 21315121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ethylcellulose and propylene glycol on the controlled-release performance of glyceryl monooleate-mertronidazole periodontal gel.
    Sallam AS; Hamudi FF; Khalil EA
    Pharm Dev Technol; 2015 Mar; 20(2):159-68. PubMed ID: 24262092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrageenan as an efficient drug release modifier for ethylcellulose-coated pharmaceutical dosage forms.
    Siepmann F; Muschert S; Zach S; Leclercq B; Carlin B; Siepmann J
    Biomacromolecules; 2007 Dec; 8(12):3984-91. PubMed ID: 18039003
    [No Abstract]   [Full Text] [Related]  

  • 16. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2012 Jan; 101(1):342-53. PubMed ID: 21935949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the coating-dependent release mechanism of a pulsatile capsule using NMR microscopy.
    Sutch JC; Ross AC; Köckenberger W; Bowtell RW; MacRae RJ; Stevens HN; Melia CD
    J Control Release; 2003 Oct; 92(3):341-7. PubMed ID: 14568414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
    Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY
    Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.